Open AccessThe alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid and endocannabinoid metabolites associated with inflammation in vivo
Author(s) -
Monte S. Willis,
Amro Ilaiwy,
Megan D. Montgomery,
Paul Simpson,
Brian C. Jensen
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/qf6f-f591
Subject(s) - endocannabinoid system , agonist , polyunsaturated fatty acid , in vivo , inflammation , pharmacology , receptor , chemistry , adrenergic receptor , adrenergic , alpha (finance) , endocrinology , medicine , fatty acid , biology , biochemistry , microbiology and biotechnology , construct validity , nursing , patient satisfaction
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom